Physical Therapy Department, Federal University of Bahia - UFBA, Salvador, Bahia, Brazil; Programa de Pós-Graduação em Medicina e Saúde - UFBA, Salvador, BA, Brazil; Physiotherapy Research Group, UFBA, Brazil; The GREAT Group (GRupo de Estudos em ATividade física), Brazil.
Programa de Pós-Graduação em Medicina e Saúde - UFBA, Salvador, BA, Brazil.
Int J Cardiol. 2019 Oct 15;293:165-175. doi: 10.1016/j.ijcard.2019.02.050. Epub 2019 Jun 24.
The aim of this study was to investigate the effects of combined aerobic and resistance training on peak oxygen consumption (peak VO), minute ventilation/carbon dioxide production (VE/VCO slope), muscle strength and health-related quality of life (HRQoL) in heart failure patients with reduced left ventricular ejection fraction (HFrEF).
We searched Cochrane, Pubmed, and PEDro (from the earliest date available to September 2018) for RCTs that evaluated the effects of combined aerobic and resistance training in HFrEF patients. Weighted mean differences (WMD), standardized mean difference (SMD), and 95% confidence interval (CI) were calculated.
39 studies met the study criteria, including 2008 patients, 14 compared combined aerobic and resistance training versus aerobic training, and 25 compared combined aerobic and resistance training versus control. Compared to aerobic training, combined aerobic and resistance training resulted in improvement in muscle strength SMD 0.7 (95% CI: 0.3 to 1.0 N = 167) and, HRQoL WMD -2.6 (95% CI: -5.0 to -0.1 N = 138). A nonsignificant difference in peak VO and VE/VCO slope was found for participants in the combined aerobic and resistance training group compared with aerobic training group. Compared to control, combined aerobic and resistance training resulted in improvement in peak VO WMD 2.9 (95% CI: 1.6 to 4.4 N = 638), muscle strength SMD 0.64 (95% CI: 0.4 to 0.9 N = 315) and, HRQoL WMD -9.8 (95% CI: -15.2 to -4.5 N = 524).
Combined aerobic and resistance training improves peak VO, muscle strength and HRQoL and should be considered as a component of care of HFrEF patients.
本研究旨在探讨有氧和抗阻联合训练对射血分数降低的心力衰竭(HFrEF)患者峰值摄氧量(peak VO)、分钟通气量/二氧化碳产量斜率(VE/VCO 斜率)、肌肉力量和健康相关生活质量(HRQoL)的影响。
我们在 Cochrane、Pubmed 和 PEDro(从最早可获得的日期到 2018 年 9 月)中检索了评估 HFrEF 患者有氧和抗阻联合训练效果的 RCTs。计算了加权均数差(WMD)、标准化均数差(SMD)和 95%置信区间(CI)。
39 项研究符合研究标准,共纳入 2008 例患者,其中 14 项比较了有氧和抗阻联合训练与单纯有氧训练,25 项比较了有氧和抗阻联合训练与对照组。与单纯有氧训练相比,有氧和抗阻联合训练可改善肌肉力量 SMD 0.7(95%CI:0.3 至 1.0;N=167)和 HRQoL WMD-2.6(95%CI:-5.0 至-0.1;N=138)。在有氧和抗阻联合训练组与单纯有氧训练组比较,峰值 VO 和 VE/VCO 斜率差异无统计学意义。与对照组相比,有氧和抗阻联合训练可改善峰值 VO WMD 2.9(95%CI:1.6 至 4.4;N=638)、肌肉力量 SMD 0.64(95%CI:0.4 至 0.9;N=315)和 HRQoL WMD-9.8(95%CI:-15.2 至-4.5;N=524)。
有氧和抗阻联合训练可提高峰值 VO、肌肉力量和 HRQoL,应作为 HFrEF 患者治疗的一部分。